Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Treatment for Cornelia de Lange Syndrome (CLoSER)
NCT06789783Phase 3Recruiting
- Sponsor
- University of Milan
- Start
- May 2024
- Primary completion
- Sep 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of lithium carbonate in Cornelia de Lange syndrome (CdLS), sponsored by University of Milan. Started May 2024; status: recruiting.
02
Drugs
lithium carbonate
03
Conditions
Cornelia de Lange syndrome (CdLS)
Beyond the preview
Go deeper on NCT06789783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789783.